A coinfection model for HIV and HCV

We study a mathematical model for the human immunodeficiency virus (HIV) and hepatites C virus (HCV) coinfection. The model predicts four distinct equilibria: the disease free, the HIV endemic, the HCV endemic, and the full endemic equilibria. The local and global stability of the disease free equilibrium was calculated for the full model and the HIV and HCV submodels. We present numerical simulations of the full model where the distinct equilibria can be observed. We show simulations of the qualitative changes of the dynamical behavior of the full model for variation of relevant parameters. From the results of the model, we infer possible measures that could be implemented in order to reduce the number of infected individuals.

[1]  Oluwole Daniel Makinde,et al.  Mathematical Modelling of HIV/AIDS Dynamics with Treatment and Vertical Transmission , 2012 .

[2]  M. Danta,et al.  Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. , 2010, AIDS.

[3]  F. Nyabadza,et al.  Modelling HIV/AIDS in the presence of an HIV testing and screening campaign. , 2011, Journal of theoretical biology.

[4]  J. Watmough,et al.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. , 2002, Mathematical biosciences.

[5]  Peter Vickerman,et al.  Assessing the cost-effectiveness of interventions linked to needle and syringe programmes for injecting drug users: An economic modelling report Authors , 2008 .

[6]  Peter Vickerman,et al.  Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact. , 2012, Drug and alcohol dependence.

[7]  Claver P. Bhunu,et al.  Modelling the transmission dynamics of HIV/AIDS and hepatitis C virus co-infection , 2013 .

[8]  V. Lakshmikantham,et al.  Stability Analysis of Nonlinear Systems , 1988 .

[9]  M. Kretzschmar,et al.  Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. , 2012, Epidemics.

[10]  Qilong Yi,et al.  Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis , 2008, AIDS.

[11]  Willis C. Maddrey,et al.  EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. , 1999, Journal of hepatology.

[12]  Paul Waltman,et al.  The Theory of the Chemostat , 1995 .

[13]  M. Sulkowski,et al.  Viral hepatitis and HIV coinfection. , 2008, Journal of hepatology.

[14]  J. Hoofnagle,et al.  Hepatitis C: The clinical spectrum of disease , 1997, Hepatology.

[15]  F. Fuchs,et al.  Risk factors for hepatitis C virus infection in individuals infected with the HIV. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[16]  Ziv Shkedy,et al.  A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective. , 2013, Epidemics.

[17]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[18]  Christophe Fraser,et al.  HIV-1 transmission, by stage of infection. , 2008, The Journal of infectious diseases.

[19]  David Greenhalgh,et al.  Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. , 2013, Drug and alcohol dependence.

[20]  Eugene R. Schiff,et al.  National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.

[21]  Ester Cerdeira Sabino,et al.  GBV-C/HGV and HIV-1 coinfection. , 2005, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.